Targeting antigen-presenting cells by anti–PD-1 nanoparticles augments antitumor immunity

Recent studies in cancer research have focused intensely on the antineoplastic effects of immune checkpoint inhibitors. While the development of these inhibitors has progressed successfully, strategies to further improve their efficacy and reduce their toxicity are still needed. We hypothesized that...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JCI Insight
Autori principali: Ordikhani, Farideh, Uehara, Mayuko, Kasinath, Vivek, Dai, Li, Eskandari, Siawosh K., Bahmani, Baharak, Yonar, Merve, Azzi, Jamil R., Haik, Yousef, Sage, Peter T., Murphy, George F., Annabi, Nasim, Schatton, Tobias, Guleria, Indira, Abdi, Reza
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Clinical Investigation 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6237477/
https://ncbi.nlm.nih.gov/pubmed/30333312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.122700
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi